Clovis Oncology Has Returned 68.7% Since SmarTrend Recommendation (CLVS)

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on July 25th, 2018 at $44.69. In approximately 3 months, Clovis Oncology has returned 68.72% as of today's recent price of...